|
|
Other links at Articles > Business of Medicine |
| 2. |
Melanoma Vaccine Study Misses Primary Goal
|
|
|
The late-stage trial of the metastatic melanoma vaccine Oncophage did not meet its primary goal of overall survival, vaccine maker Antigenics Inc said. Reuters Health Information
|
|
|